miltefosine has been researched along with 9,10-dimethyl-1,2-benzanthracene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, MR; Eibl, H; Engel, J; Hilgard, P; Schumacher, W; Stekar, J; Unger, C; Voegeli, R | 1 |
| Engel, J; Hilgard, P; Kutscher, B; Maurer, HR; Nössner, G; Schumacher, W; Stekar, J; Voegeli, R | 1 |
| Engel, J; Hilgard, P; Klenner, T; Kutscher, B; Nössner, G; Stekar, J | 1 |
3 other study(ies) available for miltefosine and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benzopyrenes; Choline; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Leukocytosis; Mammary Neoplasms, Experimental; Phosphorylcholine; Rats; Rats, Inbred Strains; Sarcoma, Experimental | 1988 |
Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Cell Differentiation; Female; Ferrets; Mammary Neoplasms, Experimental; Phosphorylcholine; Piperidines; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured; Vomiting | 1993 |
D-21266, a new heterocyclic alkylphospholipid with antitumour activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1997 |